Gene Query: NT5E

Dataset Description Geneva Score
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 198.79
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 130.55
EWSR1 influences alternative splicing through direct and indirect mechanisms 123.85
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 121.14
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 116.84
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 113.95
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 111.89
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 96.96
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 93.25
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 90.05
PNET animal model: new insights (II) 84.65
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 83.75
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 83.52
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 81.8
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 81.8
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 80.11
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 75.32
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 75.13
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 72.0
RNA-seq analyisis of PUM2 knockout cells 71.7
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 71.14
RNA-Seq analysis of breast cancer cells after shikonin treatment 70.54
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 69.41
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 68.23
DJ-1 is dispensable for human stem cell homeostasis 67.46
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 67.27
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 65.81
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 64.78
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 63.82
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 63.82
Role of CD133 molecule in WNT response and renal repair 63.05
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 62.33
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 62.21
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 62.16
Nucleoporin-mediated regulation of cell identity genes 60.2
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 59.98
hTERT promotes cell adhesion and migration independent of telomerase activity 59.72
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 58.96
Primary human trophoblast from term placenta 58.51
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 57.8
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 57.8
RNA-seq analysis of BAP1-depleted uveal melanoma cells 57.32
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 57.21
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 56.98
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 56.29
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 55.42
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 55.42
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 54.96
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 54.96
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 54.83
UBC9 knockdown in bladder cancer T24 cell lines 54.55
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 54.37
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 53.87
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 53.27
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 53.08
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 53.08
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 52.98
MARCKS and lnc-MARCKS act as inflammation regulators 52.95
Transcriptional effect of ETV1 knockdown in melanoma cells 51.43
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 51.42
BAF controls genome accessibility 51.3
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 50.82
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 50.51
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 50.51
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 50.23
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 50.23
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 49.45
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 49.45
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 49.39
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 48.85
RNAseq of IL-36 stimulated primary human keratinocytes 48.2
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 47.51
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 47.45
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 46.49
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 46.44
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 46.39
FOXD3 is a novel tumor suppressor in lung cancer 46.37
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 45.88
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 45.57
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 45.43
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 45.39
Genome-wide chromatin analysis of Ewing sarcoma 45.15
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 45.15
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 44.85
G-quadruplex structures mark human regulatory chromatin 44.65
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 44.49
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 44.15
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 44.07
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 44.05
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 43.63
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 43.59
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 43.44
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 42.27
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 42.27
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 42.12
NKX2.2 42.12
WRN knockout effects upon gene expression in SW48 and OVK18 41.62
Transcriptome of U251 cells overexpression complement component 7 41.61
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 41.31
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 41.24
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 41.18
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 41.15
METTL3 promotes translation in human cancer cells 41.14
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 41.09
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 40.46
Effect of Influenza virus infection on lncRNA expression in A549 cells 40.29
Role of FGFR1 in neuronal devlopment 40.02
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 39.9
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 39.84
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 39.84
RNA-seq of human fibroblasts after irradiation 39.83
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 39.55
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 39.34
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 39.32
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 39.28
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 39.13
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 39.09
RNA seq_PDX2_SHP099 38.92
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 38.74
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 38.71
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 38.66
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 38.56
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 38.43
Transcriptome profiling of Normal and Cancerous Prostate Cells 38.37
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 38.08
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 37.99
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 37.99
RNA expression following TMPRSS11B overexpression or depletion 37.86
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 37.43
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 37.08
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 36.78
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 36.33
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 36.32
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 36.32
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 36.31
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 36.31
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 36.2
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 36.01
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 36.01
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 35.96
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 35.37
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 34.88
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 34.81
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 34.8
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 34.78
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 34.23
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 33.86
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 33.78
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 33.6
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 33.6
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 33.41
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 33.29
RNA-seq of human aneuploid cell lines with Trisomy 21 33.28
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 33.15
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 33.03
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 32.45
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 32.45
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 32.1
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 32.05
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 32.05
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 32.05
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 31.99
FOXP1 orchestration of ASD-relevant signaling pathways. 31.84
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 31.79
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 31.79
EWS-Fli and LNC regulated genes in comparison to GFP samples 31.65
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 31.63
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 31.61
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 31.6
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 31.3
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 31.3
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 31.12
RNA sequencing of BT142 and TS603 cell lines 31.12
Spliceosomal disruption of the non-canonical BAF complex in cancer 31.04
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 30.98
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 30.82
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 30.69
Gene expression profile of human placenta from T. Cruzi infected mothers 30.34
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 30.31
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 29.83
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 29.57
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 29.47
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 29.23
Transcriptomes of human monocytes after ex vivo exposure to uric acid 29.19
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 28.99
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 28.93
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 28.91
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 28.56
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 28.46
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 28.43
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 28.43
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 28.42
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 28.42
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 28.29
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 28.27
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 28.26
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 28.24
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 28.2
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 28.2
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 28.15
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 28.05
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 28.05
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 27.65
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 27.56
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 27.38
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 27.37
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 26.97
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 26.95
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 26.68
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 26.68
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 26.36
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 26.25
Chromatin-informed inference of transcriptional programs in gynecologic cancers 26.25
Differentially expressed vascular development genes for iPSC-ECs from CDI 26.19
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 26.15
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 25.85
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 25.85
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 25.72
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 25.59
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 25.38
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 25.38
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 25.24
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 25.11
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 25.09
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 24.89
Gene expression profile in breast cancer cell lines using RNA sequencing 24.65
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 24.62
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 24.48
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 24.35
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 24.18
Fusion discovery in breast cancer cell line 24.01
High-efficiency RNA-based reprogramming of human primary fibroblasts 23.84
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 23.8
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 23.8
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 23.73
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 23.65
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 23.64
Effect of FGF13 depletion on the H460 cell line 23.61
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 23.54
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 23.51
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 23.48
Effect of disulfiram treatment on pediatric high grade glioma 23.46
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 23.26
ARID1A and ARID1B loss in HCT116 cells 23.18
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 23.12
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 23.12
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 23.06
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 23.03
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 22.9
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 22.89
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 22.81
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 22.81
Silencing SPIB in attached and floating state of H1703 lung cancer cells 22.74
Differential expression of genes in AD169-infected MRC5. 22.62
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 22.47
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  22.36
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 22.32
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 22.21
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 22.2
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 22.2
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 22.18
MOF acetyl transferase regulates transcription and respiration in mitochondria 22.09
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 22.07
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 22.06
RNA-sequencing of human liver tissue 22.02
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 21.98
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 21.96
Transcriptome analysis of BAP1 knockout and restoration 21.95
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 21.95
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 21.8
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 21.78
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 21.75
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 21.75
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 21.75
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 21.75
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 21.69
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 21.68
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 21.68
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 21.49
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 21.44
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 21.31
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 21.19
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 21.19
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 21.1
RNA-seq analysis and shRNA screen of breast cancer 20.93
RNA-seq analysis of breast cancer 20.93
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 20.9
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 20.85
Regionally specified human pluripotent stem cell-derived astrocytes 20.84
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 20.79
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 20.69
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 20.47
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 20.46
CD73 knockdown effect in pancreatic cancer cell lines 20.41
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 20.35
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 20.34
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 20.15
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 20.15
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 19.95
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 19.95
Gene Expression Profiling of SPOP Knocked Down Cell 19.86
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 19.8
Next Generation Sequencing of human SMA and healthy control Motor Neurons 19.73
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 19.66
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 19.6
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 19.45
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 19.29
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 19.29
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 19.19
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 19.13
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 19.06
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 19.05
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 19.04
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 19.01
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 18.97
A549 cell transcriptome responses to infection with H7N9 influenza virus 18.94
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 18.79
RNA-seq of MCF10A cells and CAF 18.57
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 18.54
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 18.54
Identification of differentially expressed genes between senescence and senescence bypass cells 18.34
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 18.31
Modeling Familial Cancer with iPSC Approaches 18.29
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 18.19
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 18.16
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 18.12
Transcriptome profiling of 5 human adenocarcinoma cell lines 18.04
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 17.99
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 17.76
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 17.68
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 17.68
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 17.63
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 17.59
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 17.53
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 17.43
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 17.36
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 17.3
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 17.18
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 17.13
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 16.88
Gene expression patterns define the hepatocyte-like cells derived by different strategies 16.88
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 16.84
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 16.82
The Genomic Landscape of Atypical Fibroxanthoma 16.8
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 16.55
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 16.49
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 16.4
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 16.38
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 16.38
High-Throughput Kinetic Analysis of Fractional Killing 16.25
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 16.17
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 16.11
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 15.99
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 15.69
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 15.69
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 15.31
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 15.28
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 14.96
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 14.93
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 14.79
Gene expression changes in human melanoma cell lines compared to primary melanocytes 14.68
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 14.63
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 14.59
Identification of long noncoding RNAs regulated by p53 14.55
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 14.44
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 14.41
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 14.35
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 14.35
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 14.33
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 14.27
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 14.25
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 14.09
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 13.8
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 13.75
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 13.67
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 13.56
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 13.09
Primate transcript and protein expression levels evolve under compensatory selection pressures 12.99
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 12.98
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 12.98
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 12.64
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 12.54
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 12.53
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 12.39
Gene profiling of human adult and pediatric liver cancer cells 12.26
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 12.19
IRF1 regulates IFN dependent and independent gene expression 12.15
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 12.06
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 11.88
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 11.7
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 11.5
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 11.38
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 11.27
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 11.21
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 11.19
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 11.19
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 11.17
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 11.13
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 11.13
Identification of Sin3B regulated genes during quiescence 10.96
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 10.66
RNA-seq of cancer cell lines treated with T-025 10.66
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 10.34
Gene expression profiling of human and murine in vitro muscle differentiation 10.31
Functional astrocytes differentiated from hiPSCs 9.97
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 9.8
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 9.36
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 9.33
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 9.31
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 9.31
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 9.29
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 9.15
The cytokine environment influence on human skin-derived T cells 8.99
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 8.93
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 8.85
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 8.75
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 8.51
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 8.17
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 7.71
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 7.71
Metabolism as an early predictor of DPSCs aging 7.7
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 7.62
Transcriptome-wide response to synthetic chromatin protein PcTF 7.34
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 7.29
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 7.25
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 7.14
An acquired vulnerability of drug resistant melanoma with therapeutic potential 7.14
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 7.0
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 7.0
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 6.75
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 6.71
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 6.58
Transcriptome of EBV-infected gastric cancer cell lines 6.36
NHLRC1 re-expression in cancer cells 6.24
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 6.21
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 6.17
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 6.06
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 5.84
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 5.76
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 5.76
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 5.75
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 5.71
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 5.69
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 5.68
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 5.26
RNA-seq in endometrial stromal tumors 5.2
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 4.97
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 4.97
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 4.87
Exogenous rescue of KLHL9 in SF210 cell line 4.83
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 4.76
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 4.58
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 4.55
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 4.55
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 4.54
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 4.47
RNA-Seq of Breast and Ovarian Cancer Cell Lines 4.36
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 4.22
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 4.17
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 4.17
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 4.11
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.99
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.94
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 3.84
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 3.8
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.78
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 3.54
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 3.44
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.36
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.36
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 3.32
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 2.98
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 2.93
Zika virus infection reprograms global transcription of host cells to allow sustained infection 2.8
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.5
mRNA differential expression analysis in a human ex vivo model of chronic wounds 2.48
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 2.3
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 2.23
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 1.97
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.75
Changes in human endometrial gland transcriptome over the window of implantation 1.73
Transcriptional responses of melanoma cells to BRAF inhibition 1.56
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.3
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 1.27
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.27
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.21
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 1.13
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 1.09
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.07
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.02
mRNA sequencing of oropharyngeal cancer cell lines 0.93
hNSCs siRNA NOVA2 0.88
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.66
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.6
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.54
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.53
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.48
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 0.35
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.27
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.2


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation